Nefazodone in major depression: Adjunctive benzodiazepine therapy and tolerability

Journal of Clinical Psychopharmacology

Volumn 18, Issue 2, 1998, Pages 145-153

  Rickels, Karl ^a   Schweizer, Edward ^a   Case, W George ^a   Demartinis, Nicholas ^a   Greenblatt, David J ^b   Mandos, Laura A ^a   España, Felipe Garcia ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; NEFAZODONE; TEMAZEPAM; TRIAZOLAM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; HAMILTON SCALE; HUMAN; INSOMNIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; SEDATION; SLEEP PATTERN;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BENZODIAZEPINES; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRIAZOLES;

EID: 0031923977     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199804000-00007     Document Type: Article

References (25)

1. von Moltke LL, Greenblatt DJ, Duan SX, Harmatz JS, Shader RI. In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction. J Clin Pharmacol 1994a;341:222-7.
2. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-6.
3. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
4. Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G. A double-blind comparison of nefazodone, imipramine, and placebo in major depression. J Clin Psychiatry 1994;55:234-11.
5. Rickels K, Schweizer E, Clary C, Fox I, Weise C. Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry 1994;164:802-5.
6. Mayol RF, Cole CA, Luke GM, Colson KL, Kerns EH. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma. Drug Metab Dispos 1994;22:304-11.
7. van Laar MW, van Willigenburg AP, Volkerts ER. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 1995;15:30-40.
8. Kaul S, Shukla UA, Barbhaiya RH. Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses. J Clin Pharmacol 1995;35:830-9.
9. von Moltke LL, Greenblatt DJ, Schmider J, Harmatz JS, Shader RI. Nefazodone in vitro: metabolic conversions and inhibition of P450-3A isoforms. Clin Pharmacol Ther 1996;59:176.
10. Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 1989:36:89-96.
11. von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI. Inhibitors of alprazolam metabolism in vitro: effect of serotonin reuptake inhibitor antidepressants, ketoconazole and quinidine. Br J Clin Pharmacol 1994b;38:23-31.
12. Andersson T, Miners JO, Veronese ME, Birkett DJ. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 1994;38:131-7.
13. Yasumori T, Nagata K, Yank SK, Chen L-S, Murayama N, Yamazoe Y, Kato R. Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 1993;3:291-301.
14. Greene DS, Dockens RC, Salazar DE, Barbhaiya RH. Coadministration of nefazodone and benzodiazepines I: Pharmacokinetic assessment. Clin Pharmacol Ther 1994;55:141.
15. Guy W. ECDEU assessment manual for psychopharmacology (US Department of Health, Education and Welfare publication ADM 76-338). Rockville, MD: National Institute of Mental Health, 1976.
16. Rickels K, Morris RJ, Newman H, Rosenfeld H, Schiller H, Weinstock R. Diphenhydramine in insomniac family practice patients: a double-blind study. J Clin Pharmacol 1983;23:235-42.
17. Rickels K, Morris RJ, Mauriello R, Rosenfeld H, Chung HR, Newman HM, Case WG. Brotizolam, a triazolothienodiazepine, in insomnia. Clin Pharmacol Ther 1986;40:293-9.
18. Greenblatt DJ, Ochs HR, Lloyd BL. Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacol 1980; 70:89-93.
19. Greenblatt DJ, Divoll M, Shader RI. Automated gas chromatographic determination of plasma alprazolam concentrations. J Clin Psychopharmacol 1983;3:366-8.
20. Greenblatt DJ, Divoll M, Moschitto LJ, Shader RI. Electron-capture gas chromatographic analysis of the triazolobenzodiazepines alprazolam and triazolam. J Chromatog 1981;225:202-7.
21. Locniskar A, Greenblatt DJ. Oxidative versus conjugative biotransformation of temazepam. Biopharmaceutics & Drug Disposition 1990;11:499-506.
22. von Moltke LL, Greenblatt DJ, Harmatz JS, Duan SX, Harrel LM, Cotreau-Bibbo MM, Pritchard GA, Wright CE, Shader RI. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors, and clinical confirmations of a predicted interaction with ketoconazole. J Pharmacol Exp Ther 1996;276:370-9.
23. Barbhaiya RH, Shukla UA, Kroboth PD, Greene DS. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam. J Clin Psychopharmacol 1995;15:320-6.
24. Greene DS, Salzar DE, Dockens RC, Kroboth P, Barbhaiya RH. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam. J Clin Psychopharmacol 1995a;15:399-408.
25. Greene DS, Salzar DE, Dockens RC, Kroboth P, Barbhaiya RH. Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam. J Clin Psychopharmacol 1995b;15:409-16.